News Coverage 06.07.22 Share on Twitter Share on Facebook Share on LinkedIn Three-Arm First-Line Chemoimmunotherapy Study in Patients With Metastatic Pancreatic Cancer Related Announcement, Press Release Biomarkers May Predict Better Treatment Options Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker Research Update Data to Design: Inside Our Spring Scientific Retreat